Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy
Chemotherapy forms the mainstay of cancer treatment particularly for patients who do not respond to local excision or radiation treatment. However, cancer treatment by drugs is seriously limited by P-glycoprotein (P-gp) associated multi-drug resistance (MDR) in various tumor cells. On the other hand...
Main Authors: | Tripta Bansal, Manu Jaggi, Roop Khar, Sushama Talegaonkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2009-04-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/4376 |
Similar Items
-
P-glycoprotein-dependent pharmacokinetics of irinotecan and its active metabolite, SN-38 in rats: Effect of verapamil
by: Tripta Garg, et al.
Published: (2015-03-01) -
Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms
by: Ravisha Wadhwa, et al.
Published: (2017-06-01) -
Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
by: Yusuke Kono, et al.
Published: (2021-03-01) -
ERBB and P‐glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P‐glycoprotein
by: Lisa Rösch, et al.
Published: (2023-01-01) -
Substrate versus inhibitor dynamics of P-glycoprotein.
by: Ma, J, et al.
Published: (2013)